potential indications for glp-1 receptor agonists keep expanding Balancing the benefits and risks of agonists: a clinical guide shared decision-making YGroup_weightloss GLP-1 medications like semaglutide Type:Paperback

potential indications for glp-1 receptor agonists keep expanding Balancing the benefits and risks of agonists: a clinical guide shared decision-making YGroup_weightloss GLP-1 medications like semaglutide Type:Paperback

GLP-1 medications like semaglutide and tirzepatide have quickly become some of the most talked-about drugs in diabetes and obesity care — but how much do you actually know about them? Recent peer-reviewed

Guidance from the Centers for Disease Control (CDC) published in 2024 also supports the correlation between weight loss and lowering risk for T2D

YGroup_weightloss

Type:Paperback

It differentiates between fat mass and muscle mass changes, helping ensure healthy fat loss